查看购物车
  • Traditional Chinese
  • English
  • Japanese
核医设备市场-全球及区域分析：按应用、最终用户及区域-分析与预测（2025-2035年）
市场调查报告书
商品编码
1808108

核医设备市场-全球及区域分析：按应用、最终用户及区域-分析与预测（2025-2035年）

Nuclear Medicine Equipment Market - A Global and Regional Analysis: Focus on Application, End User, Country, and Region - Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 100 Pages | 商品交期: 1-5个工作天内

价格

全球核子医学设备市场 - 分析与预测（2025-2035）

核子医学设备是使用放射性物质来诊断、治疗和管理各种疾病的专用医疗设备。

这些仪器旨在使体内过程可视化，使医疗专业人员能够检测肿瘤、心臟病、神经系统疾病等异常情况。核子医学设备通常包括正子断层扫描 (PET)、单光子发射电脑断层扫描 (SPECT) 等影像系统，以及 PET/CT 和 SPECT/CT 等混合系统。

这些设备使用放射性同位素或放射性药物，以注射、吸入或口服的方式给药。这些放射性同位素发射的辐射被成像系统拾取，从而产生内部结构和功能的详细图像。核子医学通常用于评估心臟、大脑和骨骼等器官的功能，并在癌症的检测和分期、心血管健康状况评估以及治疗效果监测方面发挥重要作用。

除了诊断成像外，核医学系统还用于治疗目的，例如靶向放射线治疗，它透过将放射性同位素直接输送到癌细胞来治疗癌症。技术的不断进步，例如整合人工智慧以实现更好的影像解释以及开发更有效率、更方便患者的系统，正在提高核医学系统的能力和可访问性。

核医设备市场的主要驱动力之一是慢性疾病（尤其是癌症、心血管疾病和神经系统疾病）盛行率的上升。随着这些疾病在全球范围内持续上升，对能够实现早期发现、准确诊断和有效治疗监测的先进诊断工具的需求也日益增长。核子医学在提供精准的非侵入性影像解决方案方面发挥关键作用，这些解决方案能够在分子层面上实现疾病可视化，帮助医疗保健提供者及早发现疾病并制定个人化治疗方案。利用PET/CT和SPECT/CT扫描仪等核医技术检测和监测复杂疾病的能力，使这些工具在现代医疗保健中发挥着不可估量的作用，从而推动市场成长。

儘管核医设备市场正在成长，但仍存在一些挑战。其中最主要的挑战之一是设备成本高。 PET/CT 和 SPECT/CT 扫描仪等核医设备需要大量投资，这对许多医疗机构，尤其是发展中地区或小型医疗中心的医疗机构来说可能是一个障碍。

初始购买、维护、安装和营运成本对于许多医疗保健组织来说过高，限制了它们获得先进诊断工具的机会并降低了采用高成本，尤其是在医疗保健预算有限和报销系统薄弱的地区。

因此，我们持续需要更具成本效益的解决方案和财务模型，以使更广泛的医疗保健提供者能够使用核子医学技术。

全球核医设备市场竞争激烈，领先公司包括西门子医疗、通用电气医疗、荷兰皇家飞利浦、佳能医疗系统、Mediso 医学影像系统、Digirad Corporation、SurgicEye GmbH、DDD-Diagnostic A/S 和东软医疗系统有限公司。这些公司处于技术创新的前沿，不断开发新技术并改进现有产品，以满足对先进核医学解决方案日益增长的需求。

西门子医疗和通用电气医疗凭藉其广泛的诊断影像系统产品组合占据市场主导地位，其中包括混合PET/CT和SPECT/CT扫描仪，这些扫描仪对于精确的诊断影像至关重要。飞利浦医疗和佳能医疗系统也凭藉其提供更高解析度和诊断准确性的高品质诊断影像设备做出了巨大贡献。 Mediso和Digirad等规模较小的公司专注于利基市场，提供固体伽马摄影机和紧凑型成像系统等专业产品，以满足对功能更丰富、价格更实惠的解决方案日益增长的需求。

这些公司也大力投资研发，将人工智慧、机器学习和改良放射性药物领域的最新进展融入其产品中。策略伙伴关係、收购和地理扩张对于在这个快速发展的市场中保持竞争力也至关重要。随着全球医疗保健系统越来越多地采用核医学技术进行疾病检测和治疗，这些市场领导将继续塑造产业的未来。

核子医学设备市场细分

细分一：按应用

  • 心臟病学
  • 肿瘤学
  • 神经病学
  • 其他的

细分 2：按最终用户

  • 医院
  • 诊断影像中心
  • 学术研究中心
  • 其他的

细分3：按地区

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

全球核子医学设备市场最重要的新兴趋势之一是将人工智慧 (AI) 和机器学习 (ML) 融入诊断影像系统。这些技术透过提高诊断准确性、优化工作流程并实现个人化治疗方案，正在彻底改变该领域。

人工智慧和机器学习演算法正越来越多地用于分析来自PET/CT和SPECT/ 电脑断层扫描的复杂影像数据，从而能够更准确地检测肿瘤、心血管疾病和神经系统疾病等异常情况。透过自动化影像解读和量化放射性示踪剂的摄取，这些技术可以帮助临床医生更快、更准确地做出诊断。此外，人工智慧主导的工具透过将影像观察与患者特定数据关联起来，促进个人化治疗策略的製定，从而实现量身定制的治疗方案。

这一趋势得到了混合成像技术的进步的支持，该技术结合了功能性和解剖性图像，可以全面洞察疾病过程。由于对更有效率、准确和个人化的医疗保健解决方案的需求，预计核子医学领域对人工智慧和机器学习的应用将继续增长。

本报告研究了全球核医设备市场，并提供了市场概述、应用、最终用户和地区的趋势以及参与市场的公司概况。

目录

执行摘要

第一章全球核子医学设备市场：产业展望

  • 介绍
  • 市场趋势
  • 法律规范
  • 专利分析
  • 案例研究
  • 产品基准
  • 市场动态

第 2 章。全球核子医学设备市场（按应用），2024-2035 年

  • 心臟病学
  • 肿瘤学
  • 神经病学
  • 其他的

3. 全球核医设备市场（依最终用户划分），2024-2035 年

  • 医院
  • 诊断影像中心
  • 学术研究中心
  • 其他的

4. 2023-2035年全球核医设备市场（按地区）

  • 北美洲
  • 欧洲
  • 亚太地区
  • 其他地区

第五章全球核子医学设备市场：竞争格局与公司概况

  • 关键策略和发展
  • 公司简介
    • Koninklijke Philips NV
    • Siemens Healthineers AG
    • GE Healthcare
    • Digirad Corporation
    • Mediso Medical Imaging Systems Ltd.
    • SurgicEye GmbH
    • Canon Medical Systems Corporation
    • DDD-Diagnostic A/S
    • Neusoft Medical Systems Co., Ltd.
    • CMR Naviscan Corporation

第六章调查方法

Product Code: BHM3237SA

Global Nuclear Medicine Equipment Market, Analysis and Forecast: 2025-2035

Nuclear medicine equipment refers to specialized medical devices used for the diagnosis, treatment, and management of various diseases using radioactive substances. These devices are designed to visualize internal bodily processes, allowing healthcare professionals to detect abnormalities such as tumors, heart disease, and neurological conditions. Nuclear medicine equipment typically includes imaging systems like Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and hybrid systems like PET/CT and SPECT/CT, which combine functional imaging with anatomical information for more precise results.

The equipment works by using radiopharmaceuticals radioactive isotopes that are either injected, inhaled, or ingested by the patient. These substances emit radiation, which is captured by the imaging system to create detailed images of the body's internal structures and functions. Nuclear medicine is often used to assess the functioning of organs like the heart, brain, and bones, and it plays a critical role in detecting and staging cancer, evaluating cardiovascular health, and monitoring treatment response.

In addition to diagnostic imaging, nuclear medicine equipment is also used for therapeutic purposes, such as targeted radiation therapy, where radioactive isotopes are used to treat cancer by delivering radiation directly to tumor cells. The continuous advancements in technology, including the integration of artificial intelligence for better image interpretation and the development of more efficient and patient-friendly systems, are enhancing the capabilities and accessibility of nuclear medicine equipment.

One of the key drivers of the nuclear medicine equipment market is the rising prevalence of chronic diseases, particularly cancer, cardiovascular diseases, and neurological disorders. As these diseases continue to increase globally, there is a growing demand for advanced diagnostic tools that can enable early detection, accurate diagnosis, and effective treatment monitoring. Nuclear medicine plays a critical role in providing precise, non-invasive imaging solutions that allow for the visualization of disease at the molecular level, helping healthcare providers to detect conditions early and tailor personalized treatment plans. The ability to detect and monitor complex diseases using nuclear medicine technologies, such as PET/CT and SPECT/CT scanners, has made these tools invaluable in modern healthcare, driving the market's growth.

Despite the growth of the nuclear medicine equipment market, several challenges persist. One of the primary challenges is the high cost of equipment. Nuclear medicine equipment, such as PET/CT and SPECT/CT scanners, requires significant investment, which can be a barrier for many healthcare facilities, especially those in developing regions or smaller medical centers.

The initial purchase cost, along with maintenance, installation, and operational costs, can be prohibitive for many institutions, limiting the accessibility of advanced diagnostic tools. This high cost can also lead to slower adoption rates, particularly in regions with limited healthcare budgets or inadequate reimbursement systems.

As a result, there is an ongoing need for more cost-effective solutions and financial models that can make nuclear medicine technologies more accessible to a broader range of healthcare providers.

The global nuclear medicine equipment market is highly competitive, with major players such as Siemens Healthineers, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems, Mediso Medical Imaging Systems, Digirad Corporation, SurgicEye GmbH, DDD-Diagnostic A/S, and Neusoft Medical Systems Co., Ltd. leading the way. These companies are at the forefront of innovation, constantly developing new technologies and enhancing existing products to meet the growing demand for advanced nuclear medicine solutions.

Siemens Healthineers and GE Healthcare dominate the market with their extensive portfolios of imaging systems, including hybrid PET/CT and SPECT/CT scanners, which are essential for accurate diagnostic imaging. Philips Healthcare and Canon Medical Systems also contribute significantly with their high-quality imaging devices that provide enhanced resolution and greater diagnostic precision. Smaller players like Mediso and Digirad focus on niche markets, offering specialized products such as solid-state gamma cameras and compact imaging systems, catering to the growing need for more versatile and affordable solutions.

These companies are also investing heavily in research and development to incorporate the latest advancements, including artificial intelligence, machine learning, and improved radiopharmaceuticals, into their products. Strategic partnerships, acquisitions, and regional expansions are also crucial to maintaining a competitive edge in this rapidly evolving market. As healthcare systems worldwide increasingly adopt nuclear medicine technologies for disease detection and treatment, these market leaders continue to shape the future of the industry.

Nuclear Medicine Equipment Market Segmentation:

Segmentation 1: by Application

  • Cardiology
  • Oncology
  • Neurology
  • Other Applications

Segmentation 2: by End User

  • Hospitals
  • Imaging Centres
  • Academic and Research Centres
  • Other End Users

Segmentation 3: by Region

  • North America
  • Europe
  • Asia-Pacific
  • Rest-of-the-World

One of the most significant emerging trends in the global nuclear medicine equipment market is the integration of artificial intelligence (AI) and machine learning (ML) into imaging systems. These technologies are revolutionizing the field by enhancing diagnostic accuracy, optimizing workflows, and enabling personalized treatment planning.

AI and ML algorithms are increasingly utilized to analyse complex imaging data from PET/CT and SPECT/CT scans, allowing for more precise detection of abnormalities such as tumours, cardiovascular issues, and neurological disorders. By automating image interpretation and quantifying radiotracer uptake, these technologies assist clinicians in making faster and more accurate diagnoses. Moreover, AI-driven tools facilitate the development of personalized treatment strategies by correlating imaging findings with patient-specific data, leading to tailored therapeutic approaches.

This trend is supported by advancements in hybrid imaging technologies, which combine functional and anatomical imaging modalities, providing comprehensive insights into disease processes. The growing adoption of AI and ML in nuclear medicine is expected to continue, driven by the demand for more efficient, accurate, and personalized healthcare solutions.

Table of Contents

Executive Summary

Scope and Definition

Market/Product Definition

Inclusion and Exclusion

Key Questions Answered

Analysis and Forecast Note

1. Global Nuclear Medicine Equipment Market: Industry Outlook

  • 1.1 Introduction
  • 1.2 Market Trends
  • 1.3 Regulatory Framework
  • 1.4 Patent Analysis
  • 1.5 Case Studies
  • 1.6 Product Benchmarking
  • 1.7 Market Dynamics
    • 1.7.1 Impact Analysis
    • 1.7.2 Market Drivers
    • 1.7.3 Market Challenges
    • 1.7.4 Market Opportunities

2. Global Nuclear Medicine Equipment Market (by Application), ($Billion), 2024-2035

  • 2.1 Cardiology
  • 2.2 Oncology
  • 2.3 Neurology
  • 2.4 Other Applications

3. Global Nuclear Medicine Equipment Market (by End User), ($Billion), 2024-2035

  • 3.1 Hospitals
  • 3.2 Imaging Centres
  • 3.3 Academic and Research Centres
  • 3.4 Other End Users

4. Global Nuclear Medicine Equipment Market (Region), ($Billion), 2023-2035

  • 4.1 North America
    • 4.1.1 Key Findings
    • 4.1.2 Market Dynamics
    • 4.1.3 Market Sizing and Forecast
      • 4.1.3.1 North America Nuclear Medicine Equipment Market, by Country
        • 4.1.3.1.1 U.S.
        • 4.1.3.1.2 Canada
  • 4.2 Europe
    • 4.2.1 Key Findings
    • 4.2.2 Market Dynamics
    • 4.2.3 Market Sizing and Forecast
      • 4.2.3.1 Europe Nuclear Medicine Equipment Market, by Country
        • 4.2.3.1.1 Germany
        • 4.2.3.1.2 U.K.
        • 4.2.3.1.3 France
        • 4.2.3.1.4 Italy
        • 4.2.3.1.5 Spain
        • 4.2.3.1.6 Rest of the Europe
  • 4.3 Asia Pacific
    • 4.3.1 Key Findings
    • 4.3.2 Market Dynamics
    • 4.3.3 Market Sizing and Forecast
      • 4.3.3.1 Asia Pacific Nuclear Medicine Equipment Market, by Country
        • 4.3.3.1.1 China
        • 4.3.3.1.2 Japan
        • 4.3.3.1.3 India
        • 4.3.3.1.4 Australia
        • 4.3.3.1.5 Rest of Asia Pacific
  • 4.4 Rest of the World
    • 4.4.1 Key Findings
    • 4.4.2 Market Dynamics
    • 4.4.3 Market Sizing and Forecast

5. Global Nuclear Medicine Equipment Market: Competitive Landscape and Company Profiles

  • 5.1 Key Strategies and Development
    • 5.1.1 Mergers and Acquisitions
    • 5.1.2 Synergistic Activities
    • 5.1.3 Business Expansions and Funding
    • 5.1.4 Product Launches and Approvals
    • 5.1.5 Other Activities
  • 5.2 Company Profiles
    • 5.2.1 Koninklijke Philips N.V.
      • 5.2.1.1 Overview
      • 5.2.1.2 Top Products / Product Portfolio
      • 5.2.1.3 Top Competitors
      • 5.2.1.4 Target Customers/End-Users
      • 5.2.1.5 Key Personnel
      • 5.2.1.6 Analyst View
    • 5.2.2 Siemens Healthineers AG
      • 5.2.2.1 Overview
      • 5.2.2.2 Top Products / Product Portfolio
      • 5.2.2.3 Top Competitors
      • 5.2.2.4 Target Customers/End-Users
      • 5.2.2.5 Key Personnel
      • 5.2.2.6 Analyst View
    • 5.2.3 GE Healthcare
      • 5.2.3.1 Overview
      • 5.2.3.2 Top Products / Product Portfolio
      • 5.2.3.3 Top Competitors
      • 5.2.3.4 Target Customers/End-Users
      • 5.2.3.5 Key Personnel
      • 5.2.3.6 Analyst View
    • 5.2.4 Digirad Corporation
      • 5.2.4.1 Overview
      • 5.2.4.2 Top Products / Product Portfolio
      • 5.2.4.3 Top Competitors
      • 5.2.4.4 Target Customers/End-Users
      • 5.2.4.5 Key Personnel
      • 5.2.4.6 Analyst View
    • 5.2.5 Mediso Medical Imaging Systems Ltd.
      • 5.2.5.1 Overview
      • 5.2.5.2 Top Products / Product Portfolio
      • 5.2.5.3 Top Competitors
      • 5.2.5.4 Target Customers/End-Users
      • 5.2.5.5 Key Personnel
      • 5.2.5.6 Analyst View
    • 5.2.6 SurgicEye GmbH
      • 5.2.6.1 Overview
      • 5.2.6.2 Top Products / Product Portfolio
      • 5.2.6.3 Top Competitors
      • 5.2.6.4 Target Customers/End-Users
      • 5.2.6.5 Key Personnel
      • 5.2.6.6 Analyst View
    • 5.2.7 Canon Medical Systems Corporation
      • 5.2.7.1 Overview
      • 5.2.7.2 Top Products / Product Portfolio
      • 5.2.7.3 Top Competitors
      • 5.2.7.4 Target Customers/End-Users
      • 5.2.7.5 Key Personnel
      • 5.2.7.6 Analyst View
    • 5.2.8 DDD-Diagnostic A/S
      • 5.2.8.1 Overview
      • 5.2.8.2 Top Products / Product Portfolio
      • 5.2.8.3 Top Competitors
      • 5.2.8.4 Target Customers/End-Users
      • 5.2.8.5 Key Personnel
      • 5.2.8.6 Analyst View
    • 5.2.9 Neusoft Medical Systems Co., Ltd.
      • 5.2.9.1 Overview
      • 5.2.9.2 Top Products / Product Portfolio
      • 5.2.9.3 Top Competitors
      • 5.2.9.4 Target Customers/End-Users
      • 5.2.9.5 Key Personnel
      • 5.2.9.6 Analyst View
    • 5.2.10 CMR Naviscan Corporation
      • 5.2.10.1 Overview
      • 5.2.10.2 Top Products / Product Portfolio
      • 5.2.10.3 Top Competitors
      • 5.2.10.4 Target Customers/End-Users
      • 5.2.10.5 Key Personnel
      • 5.2.10.6 Analyst View

6. Research Methodology

List of Figures

  • Figure: Global Nuclear Medicine Equipment Market (by Application), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market (by End User), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market (by Region), $Billion, 2024 and 2035
  • Figure: Global Nuclear Medicine Equipment Market Key Trends, Analysis

List of Tables

  • Table: Global Nuclear Medicine Equipment Market Dynamics, Impact Analysis
  • Table: Global Nuclear Medicine Equipment Market (by Region), $Billion, 2024-2035